Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) and sa-mRNA pioneer Arcturus Therapeutics (Nasdaq: ARCT) today ...

Biotechnology company Moderna (NASDAQ:MRNA) in Q4 CY2024, but sales fell by 65.6% year on year to $966 million. On the other ...

The first sa-mRNA vaccine to reach any market was Gennova Biopharmaceuticals' Gemcovac, which was launched in India in 2022 ...

A bill that would ban the use of mRNA vaccines, including for Covid-19, is on its way to the House floor after passing out of ...

Moderna (NASDAQ:MRNA) stock drops ~5% as its Q4 2024 results show revenue beat but earnings miss expectations. Read more here ...

Moderna's earnings miss expectations amid declining vaccine sales, with plans for further cost reductions in the coming years ...

CSL (CSLLY) and Arcturus Therapeutics (ARCT) announced that the European Commission has granted marketing authorization for Kostaive, a ...

The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

Moderna (MRNA), once a pandemic-era darling, has seen its stock plummet 65% over the past year, battered by fading vaccine ...

They do not contain weakened or inactivated viruses. Instead, they do contain a type of genetic information (called mRNA) with instructions on how to create copies of the coronavirus’s ‘spike’ protein ...

POSTECH Professor Won Jong Kim’s Team Develops a Next-Generation mRNA Vaccine Delivery System Using Biodegradable Polymers.